No Support For Broad Screening Of Chronic Kidney Disease
Although taught in medical school and widely used in clinical practice, broad screening of otherwise healthy people for chronic kidney disease (CKD) is unwarranted, according to new recommendations from the American College of Physicians published in the Annals of Internal Medicine. People with early kidney disease, who are classified as having stages 1 to 3 CKD, usually do not have symptoms and are generally diagnosed with labarotory tests or imaging. People who progress to advanced kidney disease are at greatly increased risk for dialysis, end-stage renal disease, and death.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Larry Husten Source Type: news
More News: Chronic Kidney Disease | Dialysis | Internal Medicine | Pharmaceuticals | Urology & Nephrology